Neoadjuvant chemotherapy: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
No edit summary |
||
| Line 1: | Line 1: | ||
{{SI}} | {{SI}} | ||
{{CMG}} | |||
==Overview== | ==Overview== | ||
'''Neoadjuvant chemotherapy''' refers to [[drug]] treatment given to people with [[cancer]] prior to surgery. The aim is to reduce the size of the cancer before surgery, thus making surgery easier and more likely to be successful. | '''Neoadjuvant chemotherapy''' refers to [[drug]] treatment given to people with [[cancer]] prior to surgery. The aim is to reduce the size of the cancer before surgery, thus making surgery easier and more likely to be successful. | ||
Revision as of 13:30, 17 August 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Neoadjuvant chemotherapy refers to drug treatment given to people with cancer prior to surgery. The aim is to reduce the size of the cancer before surgery, thus making surgery easier and more likely to be successful.